• email inquiry@market.us
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • About Us
  • Contact Us
menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • Home
  • All Reports
  • All Sectors
  • Infographics
  • News Media
    • United States
    • United Kingdom
    • Asia Pacific
  • Who Trust Us
Home / Reports / Biosimilar Monoclonal Antibodies Market
  • Home / Reports / Biosimilar Monoclonal Antibodies Market

Global Biosimilar Monoclonal Antibodies Market By Type (Human Growth Hormones, Monoclonal Antibodies, Insulin, Peptides, Erythropoietin, And Others), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, And Others), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2019-2028

  • Overview
  • Table of Contents
  • Major Market Players
  • Inquiry Before Buying
  • account_circleAbout Me
    • 12866
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now

    The report on Biosimilar Monoclonal Antibodies Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biosimilar monoclonal antibodies market is segmented on the basis of type, application, and geography.

    The Worldwide Market for Biosimilar Monoclonal Antibodies Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Biosimilar Monoclonal Antibodies Market Scope:

    By type, the market is segmented into Rituximab, Infliximab, Abciximab, Trastuzumab, Adalimumab, and Bevacizumab. By application, the market is divided into Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, and Others.

    Request Covid - 19 Impact

    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Pfizer, Inc., Novartis AG, Reliance Life Sciences, Allergan plc, Coherus BioSciences, Inc., Biocon, Dr. Reddy's Laboratories Ltd., Boehringer Ingelheim GmbH, BioXpress Therapeutics SA, Intas Pharmaceuticals Limited, BIOCAD, Genor BioPharma Co. Ltd, and Celltrion, Inc.
    .

    Key Market Segments

    Type

    • Rituximab
    • Infliximab
    • Abciximab
    • Trastuzumab
    • Adalimumab
    • Bevacizumab

    Application

    • Oncology
    • Chronic and Autoimmune Diseases
    • Growth Hormone Deficiency
    • Infectious Diseases
    • Others

    Key Market Players included in the report:

    • Pfizer, Inc.
    • Novartis AG
    • Reliance Life Sciences
    • Allergan plc
    • Coherus BioSciences, Inc.
    • Biocon
    • Dr. Reddy's Laboratories Ltd.
    • Boehringer Ingelheim GmbH
    • BioXpress Therapeutics SA
    • Intas Pharmaceuticals Limited
    • BIOCAD
    • Genor BioPharma Co. Ltd
    • Celltrion, Inc.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Biosimilar Monoclonal Antibodies Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Biosimilar Monoclonal Antibodies Market; high-growth regions; and market drivers, restraints, and also market chances.

    The analysis covers Biosimilar Monoclonal Antibodies Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biosimilar Monoclonal Antibodies Market across sections such as also application and representatives.

    Additionally, the analysis also has a comprehensive review of the crucial players on the Biosimilar Monoclonal Antibodies Market together side their company profiles, SWOT analysis, latest advancements, and business plans.


    The analysis objectives of the report are:

    • To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    • To know the Biosimilar Monoclonal Antibodies Market by pinpointing its many subsegments.
    • To profile the important players and analyze their growth plans.
    • To endeavor the amount and value of Biosimilar Monoclonal Antibodies sub-markets, depending on key regions (various vital states).
    • To analyze Biosimilar Monoclonal Antibodies Market concerning growth trends, prospects, and also their participation in the entire sector.
    • To examine and study the Biosimilar Monoclonal Antibodies Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2012 to 2018, and also prediction to 2028.
    • Primary worldwide Biosimilar Monoclonal Antibodies Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    • To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

    For the Biosimilar Monoclonal Antibodies Market research study, the following years have been considered to estimate the market size:

    Particular Scope
    Region

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Historic Year 2015 to 2020
    Estimated Year 2021
    Forecast Year 2022 to 2031

    Biosimilar Monoclonal Antibodies Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 12866
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now
    • 1. Biosimilar Monoclonal Antibodies Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Biosimilar Monoclonal Antibodies Market Overview
      • 3.1. Biosimilar Monoclonal Antibodies Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Biosimilar Monoclonal Antibodies Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Biosimilar Monoclonal Antibodies Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Rituximab
      • 4.4. Infliximab
      • 4.5. Abciximab
      • 4.6. Trastuzumab
      • 4.7. Adalimumab
      • 4.8. Bevacizumab
    • 5. Global Biosimilar Monoclonal Antibodies Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Biosimilar Monoclonal Antibodies Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Oncology
      • 5.4. Chronic and Autoimmune Diseases
      • 5.5. Growth Hormone Deficiency
      • 5.6. Infectious Diseases
      • 5.7. Others
    • 6. Global Biosimilar Monoclonal Antibodies Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Biosimilar Monoclonal Antibodies Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2.1. Europe
        • 6.2.1. Europe Biosimilar Monoclonal Antibodies Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Spain
          • 6.2.1.7. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Biosimilar Monoclonal Antibodies Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Biosimilar Monoclonal Antibodies Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Biosimilar Monoclonal Antibodies Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Biosimilar Monoclonal Antibodies Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Pfizer, Inc.
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Novartis AG
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Reliance Life Sciences
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Allergan plc
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Coherus BioSciences, Inc.
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Biocon
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. Dr. Reddy's Laboratories Ltd.
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. Boehringer Ingelheim GmbH
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. BioXpress Therapeutics SA
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. Intas Pharmaceuticals Limited
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
      • 7.13. BIOCAD
        • 7.13.1. Company Overview
        • 7.13.2. Financial Highlights
        • 7.13.3. Product Portfolio
        • 7.13.4. SWOT Analysis
        • 7.13.5. Key Strategies and Developments
      • 7.14. Genor BioPharma Co. Ltd
        • 7.14.1. Company Overview
        • 7.14.2. Financial Highlights
        • 7.14.3. Product Portfolio
        • 7.14.4. SWOT Analysis
        • 7.14.5. Key Strategies and Developments
      • 7.15. Celltrion, Inc.
        • 7.15.1. Company Overview
        • 7.15.2. Financial Highlights
        • 7.15.3. Product Portfolio
        • 7.15.4. SWOT Analysis
        • 7.15.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • ondemand_videoVideos
    • 12866
    • $3,495.00
    • $5,100.00
    • $7,200.00
    Buy Now
    • Pfizer, Inc.
    • Novartis AG
    • Reliance Life Sciences
    • Allergan plc
    • Coherus BioSciences, Inc.
    • Biocon
    • Dr. Reddy's Laboratories Ltd.
    • Boehringer Ingelheim GmbH
    • BioXpress Therapeutics SA
    • Intas Pharmaceuticals Limited
    • BIOCAD
    • Genor BioPharma Co. Ltd
    • Celltrion, Inc.
  • settingsSettings

Our Clients

Subscribe

Subscribe Now

Request for Sample


  • 12866
  • $3,495.00
  • $5,100.00
  • $7,200.00
Buy Now
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • emailinquiry@market.us

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts

Secured Payment Options

PayPal Payment System
Payoneer Payment System

© 2021 Market.Us. All Rights Reserved.

Share
Tweet
Share
Pin
0 Shares